LD-2 disclosure · 1st Quarter - Report
ALLERGAN
Client
- Name
- ALLERGAN
- Description
- Pharmeceuticals, health care company
- Location
- * Undetermined
Registrant
- Description
- Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act
LobbyistsJENNIFER HANNESSCHLAGER · TED VAN DER MEID · mr JOHN MICHAEL CLERICI · mr CHARLES RANDALL NUCKOLLS · DOUG FARRY
Covered position (TED VAN DER MEID): Counsel/Dir.Floor Operations - House Speaker
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Defense, Dept of (DOD) · Health & Human Services, Dept of (HHS)
Homeland Security
public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act
LobbyistsJENNIFER HANNESSCHLAGER · TED VAN DER MEID · mr JOHN MICHAEL CLERICI · mr CHARLES RANDALL NUCKOLLS · DOUG FARRY
Covered position (TED VAN DER MEID): Counsel/Dir. Floor Operations - House Speaker
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Defense, Dept of (DOD) · Health & Human Services, Dept of (HHS)